Skip to main content

Table 2 Review of literature for iliopsoas hematoma in chronic hemodialysis patients

From: Spontaneous iliopsoas muscle hematoma secondary to disseminated intravascular coagulation caused by nafamostat mesilate allergy: a case study

No.

Author

Years

Country

Age

Sex

Etiology of ESRD

Time on dialysis

Antiplatelets

Anticoagulants

Laterality

Treatment

Outcome

Reference

1

Delorme MA

1993

Canada

68

M

CGN

6 years

None

None

ND

ND

ND

[5]

2

Inoue T

2001

Japan

76

F

ND

ND

ND

ND

L

Conservative

Death

[6]

3

Halak M

2001

Israel

72

F

ND

ND

None

Heparin

L

Endovascular Tx

Survival

[7]

4

Malek-Marín T

2010

Spain

76

M

ADPKD

18 years

None

Warfarin

R

Conservative

Survival

[8]

5

Fan WX

2012

China

67

F

DMN

2 weeks

Ozagrel

Heparin

L

Conservative

Survival

[11]

6

Li J

2016

Hong Kong

72

M

ND

5 years

Aspirin, clopidogrel

LMWH

R

Endovascular Tx

Survival

[9]

7

Hwang NK

2017

Korea

43

M

ND

ND

ND

Heparin

L

Endovascular Tx

Survival

[10]

8

69

F

ND

ND

Aspirin, clopidogrel

Heparin

L

Endovascular Tx

Death

9

48

M

ND

4 months

Aspirin, clopidogrel, pletaal

LMWH

R

Endovascular Tx

Survival

  1. ESRD end-stage renal disease, ND not documented, L left, R right, CGN chronic glomerulonephritis, Tx treatment, ADPKD autosomal dominant polycystic kidney disease, LMWH low molecular weight heparin